On Jun 29, 2018 ZELDA THERAPEUTICS LTD. ORDINARY SHARES (OTCMKTS:ZLDAF) Shorts Rose By 3.3%

June 29, 2018 - By Catherine Smith

ZELDA THERAPEUTICS LTD. ORDINARY SHARES (OTCMKTS:ZLDAF) had an increase of its shares shorted by 3.3%. It was issued in June by FINRA the 9,400 shares shorted on ZLDAF. The up change of 3.3% from 9,100 shares was reported.

Ticker’s shares touched $0.0721 during the last trading session after 6.03% change.Currently Zelda Therapeutics Limited is after 0.00% change in last June 29, 2017. ZLDAF has 31,002 shares volume. ZLDAF underperformed the S&P 500 by 12.57%.

Zelda Therapeutics Limited, a bio-pharmaceutical company, focuses on developing a range of cannabinoid formulations for the treatment of various medical conditions in Australia.The company has $52.73 million market cap. The firm is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.Currently it has negative earnings. It has strategic alliances with Knop Laboratories and CannPal Pty Ltd; and partnerships with AusCann Limited and Aunt Zelda??s Inc, as well as the Complutens?? University, the Curtin University, and the Telethon Kids Institute.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.